Brown Advisory’s Juno Therapeutics, Inc. JUNO Stock Holding History

Brown Advisory’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-250,487	Closed	-$11.4M	–	1333
2017 Q4	$11.4M	Hold	250,487	–	–	0.04%	299
2017 Q3	$11.2M	Buy	250,487 +52	+0%	+$1.77K	0.04%	290
2017 Q2	$7.49M	Hold	250,435	–	–	0.02%	356
2017 Q1	$5.56M	Hold	250,435	–	–	0.02%	360
2016 Q4	$4.72M	Buy	+250,435	New	+$6.13M	0.02%	386
2015 Q1	–	Sell	-97,944	Closed	-$5.12M	–	968
2014 Q4	$5.12M	Buy	+97,944	New	+$4.38M	0.02%	342

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Brown Advisory's JUNO Position: Q1 2018 in Review

Brown Advisory sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 250,487 shares — an estimated $11.4M sold.

Brown Advisory first reported a position in JUNO in Q4 2014 and held it in 6 quarters. The position peaked at $11.4M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Brown Advisory reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Brown Advisory sold 250,487 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $11.4M.
Brown Advisory first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 6 quarters.
Brown Advisory's Juno Therapeutics, Inc. position peaked at $11.4M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Brown Advisory's 13F filing for Q1 2018, filed 14 May 2018.